CanadaNews

Wegovy approved in Canada to combat risk of non fatal-heart attack | EnvoyPost

Health Canada has approved Novo Nordisk’s weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults.

Related Articles

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker